13-51944303-A-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_000053.4(ATP7B):c.3061-12T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,444 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000053.4 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP7B | NM_000053.4 | c.3061-12T>A | intron_variant | Intron 13 of 20 | ENST00000242839.10 | NP_000044.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000407 AC: 1AN: 245682Hom.: 0 AF XY: 0.00000745 AC XY: 1AN XY: 134162
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461444Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727024
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Wilson disease Pathogenic:6
- -
- -
This variant causes a T to A nucleotide substitution at the -12 position of intron 13 of the ATP7B gene. A functional RNA study has shown that this variant causes in-frame skipping of exon 14 (PMID: 12325021), resulting in loss of portions of the ATP nucleotide binding domain (a.a. 1032 - 1196) and phosphorylation domains (a.a. 1004 - 1031; a.a. 1197 - 1306) that are important for ATP7B protein function (PMID: 35245129; ClinVar). This variant has been observed in individuals affected with autosomal recessive Wilson disease (PMID: 12325021, 22687675, 23567103, 32043565, 33159804, 34400371, 35169583), including in one individual in the homozygous state (PMID: 22687675) and in multiple individuals in the compound heterozygous state with another pathogenic variant in ATP7B (PMID: 23567103, 32043565, 33159804, 35169583). This variant has been identified in 1/245682 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of ATP7B function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. -
- -
This sequence change falls in intron 13 of the ATP7B gene. It does not directly change the encoded amino acid sequence of the ATP7B protein. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has been observed in individual(s) with Wilson disease (PMID: 12325021, 22687675, 23567103). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 557116). Studies have shown that this variant results in skipping of exon 14, but is expected to preserve the integrity of the reading-frame (PMID: 12325021). For these reasons, this variant has been classified as Pathogenic. -
Variant summary: ATP7B c.3061-12T>A alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: Two predict the variant abolishes a canonical 3' acceptor site. Two predict the variant weakens a canonical 3' acceptor site. At least one publication reports experimental evidence that this variant affects mRNA splicing (Loudianos_2002). The variant allele was found at a frequency of 4.1e-06 in 245682 control chromosomes. c.3061-12T>A has been reported in the literature in multiple individuals affected with Wilson Disease (example, Loudianos_2012, Silva_2011, Bost_2012, Dufernez_2013, Sanchez-Monteagudo_2020). These data indicate that the variant is very likely to be associated with disease. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. One submitter has cited overlapping evidence utilized in the context of this evaluation. Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at